The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics. WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version. The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal. WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%. |
Barry Odom signs 5Bryce Miller twirls another gem and leads the Mariners past the Cubs 4A Supreme Court social media ruling could set new free speech standardsTrump’s hush money trial will test Alvin Bragg's efforts at neutralityCalifornia court affirms Kevin McCarthy protege's dual candidacies on state ballotConservative Christians press Trump to do more on abortionCourt says judge had no authority to halt Medicare Advantage plan for Delaware government retireesBryson DeChambeau, matured in both game and attitude, opens with 65 to lead the MastersDevonte' Graham and the Spurs stun the Nuggets, who fall into a threeAndrei Kuzmenko's hat trick leads Calgary to a 6